Treating upper airway nerve tissue

US2018228533A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2018228533-A1
Application numberUS-201815952985-A
CountryUS
Kind codeA1
Filing dateApr 13, 2018
Priority dateJun 14, 2011
Publication dateAug 16, 2018
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Systems and methods for treating a patient's mucus hypersecretion condition are disclosed herein. Certain implementations may involve a method for reducing mucus secretion in an upper airway of a patient to treat at least one of post nasal drip or chronic cough. The method may include advancing a treatment delivery portion of an energy-based treatment device into a nostril of the patient. The treatment delivery portion may contact mucosal tissue of the upper airway without piercing the mucosal tissue. The treatment delivery portion may deliver treatment to at least one tissue selected from the group of the mucosal tissue and another tissue underlying the mucosal tissue to modify a property of the at least one tissue and thus treat at least one of post nasal drip or chronic cough in the patient.

First claim

Opening claim text (preview).

What is claimed is: 1 . A method for deactivating a target tissue in an airway of a patient to reduce mucus secretion, the method comprising: advancing a treatment delivery portion of an energy-based treatment device into a nostril of the patient; contacting a surface of a mucosal tissue of the airway with the treatment delivery portion, without piercing the surface of the mucosal tissue; and delivering an energy-based treatment from the treatment delivery portion to a selected tissue depth to deactivate the target tissue underlying the mucosal tissue and thus reduce mucus secretion. 2 . The method of claim 1 , wherein the target tissue comprises nerve tissue, and wherein delivering the energy-based treatment comprises ablating the nerve tissue. 3 . The method of claim 2 , wherein the nerve tissue comprises the sphenopalatine ganglion. 4 . The method of claim 1 , wherein the target tissue is selected from the group consisting of cilia, goblet cells, and submucosal tissue. 5 . The method of claim 1 , wherein delivering the energy-based treatment comprises delivering energy in a form selected from the group consisting of ultrasound, microwave, heat, radiofrequency, electrical, light, and laser energy. 6 . The method of claim 5 , wherein delivering the energy-based treatment comprises delivering radiofrequency energy from a first electrode on a tissue contact surface of the treatment delivery portion across a convex portion of the tissue contact surface to a second electrode on the tissue contact surface. 7 . The method of claim 6 , wherein the first electrode and the second electrode comprise non-piercing bumps on the tissue contact surface, and wherein contacting the surface of the mucosal tissue comprises contacting the non-piercing bumps on the tissue contact surface with the surface of the mucosal tissue. 8 . The method of claim 1 , further comprising: measuring an amount of delivered energy using a thermocouple on the treatment delivery portion; and adjusting the amount of delivered energy by adjusting a setting of the treatment delivery portion. 9 . The method of claim 1 , wherein delivering the energy-based treatment comprises applying cryotherapy. 10 . The method of claim 9 , wherein the target tissue comprises nerve tissue, and wherein applying the cryotherapy comprises ablating the nerve tissue. 11 . The method of claim 1 , further comprising applying force against the surface of the mucosal tissue with the treatment delivery portion to mechanically alter a shape of the airway while delivering the energy-based treatment.

Assignees

Inventors

Classifications

  • multiple needles · CPC title

  • being one or more injection needles · CPC title

  • having a short rigid shaft for accessing the inner body through natural openings · CPC title

  • Probes or electrodes therefor · CPC title

  • Balloons · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2018228533A1 cover?
Systems and methods for treating a patient's mucus hypersecretion condition are disclosed herein. Certain implementations may involve a method for reducing mucus secretion in an upper airway of a patient to treat at least one of post nasal drip or chronic cough. The method may include advancing a treatment delivery portion of an energy-based treatment device into a nostril of the patient. The t…
Who is the assignee on this patent?
Aerin Medical Inc
What technology area does this patent fall under?
Primary CPC classification A61B18/1485. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Aug 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).